Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresChad J. Creighton, Jenny C. Chang, Xiaoxian Li et al.|Proceedings of the National Academy of Sciences|2009Cited by 1.4k
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situFariba Behbod, Daniel Medina, Frances Kittrell et al.|Breast Cancer Research|2009Cited by 298
Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast CancerChad J. Creighton, Jeffrey M. Rosen, Jenny C. Chang|Journal of Mammary Gland Biology and Neoplasia|2010Cited by 243
Intratumoral Heterogeneity in a <i>Trp53</i> -Null Mouse Model of Human Breast CancerMei Zhang, Jeffrey M. Rosen, Anna Tsimelzon et al.|Cancer Discovery|2015Cited by 73
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transitionNa Zhao, Jeffrey M. Rosen|Nature Communications|2021Cited by 59